(Q83539279)
Statements
Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma (English)
R Maréchal
P Demetter
F Bonnetain
A Couvelard
M Svrcek
A Bardier-Dupas
C Louvet
F Paye
P Rougier
C Penna
J C Vaillant
J Closset
I Salmon
J F Emile
J L Van Laethem
29 February 2012
1 reference